$2.23
-0.1-4.50%
At close: -
$2.34
0.114.93%
After Hours: Nov 15, 8:41 AM EDT
Oramed Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Oramed Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-16 | $0.22 | $0.01 | 2100.0 % |
Mar 2024 | 2024-05-09 | $0.04 | $0.02 | 100.0 % |
Dec 2023 | 2024-03-06 | $0.33 | $-0.12 | 375.0 % |
Sep 2023 | 2023-11-09 | $-0.08 | $-0.08 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-16 | $0 | $250.00K | -100.0 % |
Sep 2023 | 2023-11-09 | $0 | $700.00K | -100.0 % |
Jun 2023 | 2023-08-10 | $674.00K | $700.00K | -3.71 % |
Mar 2023 | 2023-05-11 | $666.00K | $750.00K | -11.2 % |
Oramed Pharmaceuticals (ORMP) is scheduled to report earnings on November 29, 2024. The last reported earnings were for reported on August 16, 2024 for Q2.
The Actual EPS was $0.22, which beat the estimate of $0.01.
The Actual Revenue was $0K, which missed the estimate of $250K.
Browse earnings estimates, EPS, and revenue on all stocks.